Cholangiocarcinomas Completed Phase 1 / 2 Trials for Capecitabine (DB01101)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00350961Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced CholangiocarcinomaTreatment